Overall, these observations suggest that IGF1/IGF1R axis in cancer plays a critical role in promoting the recruitment and the maintenance of immunosuppressive macrophages with an M2 phenotype in the TME, thereby, contributing to the inhibition of anti-cancer immunity and enhancement of tumor progression (Figure 2). This evidence concerns the gene IGF1R and cancer.